Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.
about
Three decades of beta-lactamase inhibitorsUpdate on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic optionsStenotrophomonas maltophilia: an emerging global opportunistic pathogenStructure of Aminodeoxychorismate Synthase from Stenotrophomonas maltophiliaAttributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literatureEvaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill ExperimentsDengue co-infection in a blood stream infection caused by Stenotrophomonas maltophilia: A case report.Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia.Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome.Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.Stenotrophomonas maltophilia in Lower Respiratory Tract Infections.Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.Antimicrobial shortages: Another hurdle for cliniciansExpression of Sme efflux pumps and multilocus sequence typing in clinical isolates of Stenotrophomonas maltophiliaResistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.Health care associated infections, antibiotic resistance and clinical outcome: A surveillance study from Sanandaj, IranCross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.Clinical and microbiologic outcomes in trauma patients treated for Stenotrophomonas maltophilia ventilator-associated pneumonia.Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.Surveillance and management of multidrug-resistant microorganisms.Combination therapy for Gram-negative bacteria: what is the evidence?Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.Minimal Inhibitory Concentration of Ceftazidime and Co-trimoxazole for Stenotrophomonas Maltophilia using E-test.Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias.Treatment of Polymicrobial Osteomyelitis with Ceftolozane-Tazobactam: Case Report and Sensitivity Testing of Isolates.A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity against Stenotrophomonas maltophilia.Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.Unusual case of rapid growing intraabdominal abscess caused by Stenotrophomonas maltophilia after laparoscopic appendectomy due to perforated appendicitis: A case report.Genome Sequence of Stenotrophomonas maltophilia Strain AU12-09, Isolated from an Intravascular Catheter.Ex Vivo Perfusion Treatment of Infection in Human Donor Lungs.A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI.In vitro antibacterial and antibiofilm activities of chlorogenic acid against clinical isolates of Stenotrophomonas maltophilia including the trimethoprim/sulfamethoxazole resistant strain.Surveillance of antimicrobial susceptibility patterns among Stenotrophomonas maltophilia isolated in China during the 10-year period of 2005-2014.Meningitis due to Stenotrophomonas maltophilia after a Neurosurgical Procedure.
P2860
Q24646623-A4D8FB69-A0B3-4DB7-AE79-C953D50D7FD6Q26782924-8AA58B84-055D-45FC-8F85-1ADA360821EAQ26995336-31D62107-38CD-4F56-992B-EBEA7ABBD412Q27675447-7EFA9554-1559-4C71-A522-D546CB138387Q28263931-510E0C1A-27A4-4381-8965-384E6306DFA8Q28550910-D67AA14E-7014-4D87-BF1D-4947CFA646F5Q33419556-35D5537C-86FE-4E02-8247-07A81B90207FQ33909519-79091A61-80CA-49A4-9F2D-B4507D758012Q34279948-09F7A34B-C7E1-404F-8625-6106023BE43BQ35018533-8213CF7F-B0BB-465E-AB7C-7CE4353B8DB1Q35046315-B2105D63-DA61-48F6-8483-DE78DE620175Q35108518-77C12CB3-DAD9-419A-BCD1-5C7566DA5AECQ35569872-3BED372A-E880-4F3D-B551-ECE509AE82A8Q35664889-AAAE2944-B67B-411D-9C14-62BFC2C6F666Q35681397-37BDC37A-70A2-48E9-AEC0-C9CBD2B96D5FQ36687924-50ADCFDD-2CAE-44EE-82BE-C75C23A06C27Q37065167-CA7C1EF4-E4F7-48B9-A2EC-163548248576Q37377897-410D93E2-9737-45E1-BA84-991865C3EED9Q37544504-26D1F7AB-BB27-46FC-A72E-FEE0E21074B9Q37544565-60CE9FDA-A529-4E84-BE39-545B47DDC6D4Q37681071-39A12D8E-5F88-4A87-A61F-706A31EF273CQ37859361-74C96ACD-907A-4CC5-9B6E-190DB8C81DC1Q37866819-198FE16A-3301-4853-B2F5-B9FF3C86CA96Q37912231-3F586C0A-A912-40F2-97A6-8ECAA6BDF99FQ38156194-50B3FDA1-4D48-4AE8-800A-DC4EF9FA96A4Q38188881-5202B736-99A4-4168-A14B-9D097F4EFBACQ38247296-6FCCCD08-2D88-44F1-B585-E18089AE5C6BQ38265741-76419CDB-2D29-41F3-B681-BCF02E43332AQ38267323-B4EFF92F-393A-4B44-AADA-529B38D9DE8FQ39581980-2D15FF5F-6795-475A-A53C-B125828849D4Q40052282-74FA0D73-B507-4570-A66E-C7D2DC350E47Q40072110-00A70059-FB17-49CD-8C0D-E0AA198BB27CQ40209160-45694104-ED4F-4E28-A33D-0B83E51D6F7DQ40323478-339DAF49-09F0-480B-9FE8-CBF8A63C39ABQ40845626-876CCB2F-82C0-4880-9112-E9A5F8F7710BQ41111507-FBEF8A95-8CA7-49FF-BA3D-88511E10AF03Q41410636-65546585-9AE7-4CB9-B6DC-EF3B431C6D2BQ41481610-828D5F58-30AF-48D2-91E1-FA502FD674DFQ41994109-DAF73909-06C8-4211-8D41-C17325B7F8EBQ42968782-E5086B15-D730-437F-AB1B-1B574F78FC3D
P2860
Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic options for Stenot ...... moxazole: a systematic review.
@en
Therapeutic options for Stenot ...... moxazole: a systematic review.
@nl
type
label
Therapeutic options for Stenot ...... moxazole: a systematic review.
@en
Therapeutic options for Stenot ...... moxazole: a systematic review.
@nl
prefLabel
Therapeutic options for Stenot ...... moxazole: a systematic review.
@en
Therapeutic options for Stenot ...... moxazole: a systematic review.
@nl
P2860
P50
P356
P1476
Therapeutic options for Stenot ...... moxazole: a systematic review.
@en
P2093
Politimi-Eleni Valkimadi
Yu-Tsung Huang
P2860
P304
P356
10.1093/JAC/DKN301
P407
P577
2008-07-28T00:00:00Z